Healthcare startup LEESOL announced on the 28th that it was finally selected for the '2025 Baby Unicorn Development Project' hosted by the Ministry of SMEs and Startups and designated as a baby unicorn company.
Lysol has been recognized for its technological prowess and growth potential through its mental healthcare business model that combines AI-based electronic medicine technology and customized neurofeedback solutions. A total of 217 companies applied for this year’s Baby Unicorn Training Project, and 50 companies were ultimately selected, resulting in a competition rate of approximately 4.3 to 1.
The Baby Unicorn Development Project is a representative scale-up program of the Ministry of SMEs and Startups that discovers promising startups with outstanding technology and growth potential and develops them into potential unicorns with a corporate value of less than 100 billion won. Selected companies will be provided with customized support such as up to 300 million won in market development funds, up to 5 billion won in special guarantees from the Technology Guarantee Fund, global consulting, investment attraction (IR), and overseas expansion support.
Lysol Co-CEO Kwon Gu-seong said, “The selection as Baby Unicorn is the result of the government officially recognizing Lysol’s innovative technology and clinical verification data in the field of brain health,” and added, “We will grow into a digital electronic pharmaceutical company leading the global healthcare market.”
- See more related articles
You must be logged in to post a comment.